Showing results (1371-1380 of 9,902) with videos related to
Sort By:
Pageof 991
Bone Marrow Transplantation|August 23, 2005
Dental abnormalities after pediatric bone marrow transplantationM D Vaughan, C C Rowland, X Tong, et al.Bone Marrow Transplantation|August 23, 2005
Bloodless (transfusion-free) hematopoietic stem cell transplants: the Mexican experienceG J Ruiz-Argüelles, A Morales-Toquero, B López-Martínez, et al.Bone Marrow Transplantation|August 23, 2005
Survival after reduced-intensity conditioning is not inferior to standard high-dose conditioning before allogeneic haematopoietic cell transplantation in acute leukaemiasG Massenkeil, M Nagy, S Neuburger, et al.Bone Marrow Transplantation|August 3, 2005
Treatment of chronic hepatitis C virus in allogeneic bone marrow transplant recipientsR Peffault de Latour, T Asselah, V Lévy, et al.Bone Marrow Transplantation|August 3, 2005
Autologous transplantation for primary systemic AL amyloidosis is feasible outside a major amyloidosis referral centre: the Calgary BMT Program experienceL Q M Chow, N Bahlis, J Russell, et al.Bone Marrow Transplantation|June 28, 2005
Granulocyte colony-stimulating factor for poor graft function after allogeneic stem cell transplantation: 3 days of G-CSF identifies long-term respondersH Bittencourt, V Rocha, A Filion, et al.Bone Marrow Transplantation|March 22, 2005
Long-term outcome of allogeneic or autologous haemopoietic cell transplantation for acute lymphoblastic leukaemia in second remission in children. GETMON experience 1983-1998I Badell, A Muñoz, J J Ortega, et al.Bone Marrow Transplantation|March 22, 2005
Haplotype mismatched transplantation using high doses of peripheral blood CD34+ cells together with stratified conditioning regimens for high-risk adult acute myeloid leukemia patients: a pilot study in a single Korean institutionH-J Kim, W-S Min, Y-J Kim, et al.Bone Marrow Transplantation|April 5, 2005
Nonmyeloablative stem cell transplantation using lymphoablative rather than myeloablative conditioning in the prefludarabine era by ATG and limiting doses of cyclophosphamideM Bitan, R Or, M Y Shapira, et al.Bone Marrow Transplantation|March 24, 2005
Prospective evaluation of gut mucosal barrier injury following various myeloablative regimens for haematopoietic stem cell transplantN M A Blijlevens, J P Donnelly, B E de PauwPageof 991